Kyla Mckay

Kyla Mckay

Assistant Professor
Visiting address: Tomtebodavägen 18a, plan 5, 17177 Stockholm
Postal address: K8 Klinisk neurovetenskap, K8 Neuro Glaser McKay, 171 77 Stockholm
Part of:

About me

  • Assistant Professor of Neuroepidemiology
    Epidemiologist with a PhD from the University of British Columbia and
    postdoctoral training at the Karolinska Institute. My research focuses
    largely on the causes and consequences of multiple sclerosis.
    *Assistant Professorship* - Karolinska Institutet - April 2023 to April 2028
    *Forte Postdoctoral Award - *Swedish Research Council for Health, Working
    Life and Welfare – January 2020 to 2022
    *endMS Postdoctoral Fellowship Award - *Multiple Sclerosis Society of Canada
    – September 2020 to 2021 (declined)
    *Forskningsbidrag (R**esearch Grant) - *Svenska MS-Sällskapet (Swedish
    MS Association) – January 2020
    *Karolinska Institutet Internship Program - *Försvarsmakten (Swedish Armed
    Forces) – August 2019 to October 2019
    *Early-career investigator scholarship *- Columbia University, USA – May
    2019
    *Forskningsanslag (Research grant)* - Neuroförbundet – January 2018 to
    December
    2019
    *Postdoctoral Research Fellowship Exchange Award - *European Committee for
    Treatment and Research in Multiple Sclerosis (ECTRIMS) – September 2017 to
    2019
    *Postdoctoral Fellowship Award * - Canadian Institutes of Health Research
    – September 2017 to 201
    *PhD* in Experimental Medicine - University of British Columbia, Vancouver,
    British Columbia, Canada (June 2017)
    Dissertation: /Using linked health data to investigate the epidemiology and
    impact of mental health and health behaviours in multiple sclerosis/
    *Bachelor of Science* – Major in Neuroscience - Dalhousie University,
    Halifax, Nova Scotia, Canada (May 2008)

Research

  • Multiple sclerosis (MS) is a chronic, progressively disabling disease of the
    central nervous system. Its aetiology is not fully understood and it has no
    known cure. Between 3 and 10% of persons with MS experience their first
    neurological symptoms in childhood. Though paediatric MS accounts for a small
    percentage of all cases, it is particularly distressing to patients and their
    families. Few population-based studies have investigated the demographic and
    clinical characteristics of MS in children, which contributes to uncertainty
    in the management of the disease.
    My research focuses on better understanding what causes paediatric multiple
    sclerosis. We believe that a focus on this cohort of patients will help us
    understand the aetiology of disease in the wider MS population. Our research
    capitalizes on the wealth of population-based health data available in
    Sweden.

Articles

All other publications

Grants

News from KI

Events from KI